IGM Biosciences, Inc.
CD20 BINDING MOLECULES AND USES THEREOF

Abstract:

This disclosure provides pentameric and hexameric CD20 binding molecules and methods of using such molecules to direct complement-mediated, T-cell-mediated, or both complement-mediated and T-cell-mediated killing of CD20-expressing cells.